全文获取类型
收费全文 | 16024篇 |
免费 | 1675篇 |
国内免费 | 501篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 395篇 |
妇产科学 | 294篇 |
基础医学 | 1709篇 |
口腔科学 | 116篇 |
临床医学 | 1244篇 |
内科学 | 2144篇 |
皮肤病学 | 221篇 |
神经病学 | 849篇 |
特种医学 | 723篇 |
外国民族医学 | 10篇 |
外科学 | 1347篇 |
综合类 | 2374篇 |
现状与发展 | 3篇 |
预防医学 | 769篇 |
眼科学 | 688篇 |
药学 | 1944篇 |
13篇 | |
中国医学 | 646篇 |
肿瘤学 | 2672篇 |
出版年
2024年 | 38篇 |
2023年 | 313篇 |
2022年 | 358篇 |
2021年 | 753篇 |
2020年 | 628篇 |
2019年 | 667篇 |
2018年 | 634篇 |
2017年 | 665篇 |
2016年 | 755篇 |
2015年 | 721篇 |
2014年 | 1101篇 |
2013年 | 1292篇 |
2012年 | 998篇 |
2011年 | 985篇 |
2010年 | 873篇 |
2009年 | 751篇 |
2008年 | 740篇 |
2007年 | 736篇 |
2006年 | 646篇 |
2005年 | 557篇 |
2004年 | 464篇 |
2003年 | 482篇 |
2002年 | 399篇 |
2001年 | 350篇 |
2000年 | 279篇 |
1999年 | 226篇 |
1998年 | 185篇 |
1997年 | 186篇 |
1996年 | 157篇 |
1995年 | 119篇 |
1994年 | 142篇 |
1993年 | 113篇 |
1992年 | 95篇 |
1991年 | 83篇 |
1990年 | 73篇 |
1989年 | 79篇 |
1988年 | 60篇 |
1987年 | 49篇 |
1986年 | 49篇 |
1985年 | 67篇 |
1984年 | 44篇 |
1983年 | 29篇 |
1982年 | 47篇 |
1981年 | 40篇 |
1980年 | 38篇 |
1979年 | 27篇 |
1978年 | 19篇 |
1977年 | 20篇 |
1976年 | 20篇 |
1975年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
目的 :探讨小瞳孔状态下超声乳化的手术技巧和注意事项。方法 :应用非切开瞳孔牵拉扩张法及部分下方瞳孔缘括约肌剪断法原位超声乳化碎核等技术对 38例小瞳孔白内障行超声乳化。结果 :38只眼中 1 7眼未用扩张器 ,9眼应用扩张器 ,术后瞳孔恢复原状 ;1 2只眼需剪开下方瞳孔括约肌及剪除机化膜 ,术后瞳孔略欠圆。术后一个月裸眼视力≥ 0 .5者 2 1眼 (2 1 / 38) ,矫正视力≥ 0 .5者 32眼(32 / 38)。结论 :白内障超声乳化术可使小瞳孔白内障术后恢复生理性圆瞳孔 ,无不良反应。 相似文献
22.
23.
Sylvain Miraux Jean-Michel Franconi Eric Thiaudière 《Magnetic resonance in medicine》2006,56(3):469-473
Blood velocity is a functional parameter that is not easily assessed noninvasively, especially in small animals. A new noninvasive method that uses magnetic resonance angiography (MRA) to measure blood flows is proposed. This method is based on the time-of-flight (TOF) phenomenon. By initially suppressing the signal from the stationary spins in the area of interest, it is possible to sequentially visualize only the signal from the moving spins entering a given volume. With this method, 3D cine images of the blood flow can be generated by positive contrast, with unparalleled spatial (<200 microm) and temporal resolutions (<10 ms/image). As a result, it is possible to measure flow in sinuous paths. The present method was applied in vivo to measure the blood velocity in mouse carotid arteries. Because of its robustness and simplicity of implementation, this method has numerous potential applications for fundamental studies in small animal models. 相似文献
24.
小肠浆肌膜腔内自体脾组织移植动物模型的建立与意义 总被引:2,自引:2,他引:0
目的探讨增加自体脾组织移植量的方法,提高自体移植脾组织的功能。方法贵州小型香猪3头,经肌注麻醉后剖腹切除脾脏,取脾脏的1/2约150g,切成1mm×1mm×1mm小块备用。在距Treitz韧带50cm处,切取保留肠系膜血管的空肠30cm旷置,再吻合肠管恢复肠腔通道,缝闭肠系膜裂口。旷置空肠等分2段,去除肠粘膜,缝闭一端,将约50g脾组织块分别植于2段肠浆肌膜腔内,缝闭另一端口,妥善固定于肠系膜上。大网膜内移植30g脾组织作为对照观察。结果4个月饲养期间内无肠梗阻发。3段肠浆肌膜腔内脾组织再生良好,组织结构与大网膜内移植脾组织无明显差别,2段再生较差,1段形成脓肿。结论肠浆肌膜腔内移植脾组织的量较大,可作为自体脾组织的移植术式。 相似文献
25.
目的 提高对膀胱小细胞癌的认识。 方法 回顾性分析 6例膀胱小细胞癌患者的病理及临床资料。男 4例 ,女 2例 ,平均年龄 5 1岁。其中 2例膀胱小细胞癌含有移行细胞癌和 (或 )腺癌成分。行膀胱部分切除术 2例 ,行膀胱全切术 4例。 5例患者接受 2~ 6疗程化疗。 结果 6例患者随访 12~ 6 0个月 ,均因肿瘤复发死亡。平均生存时间 2 8个月。 结论 膀胱小细胞癌占原发膀胱恶性肿瘤的 0 .4 4 % ,恶性程度高 ,易发生淋巴结、肝、骨等转移 ,预后差 ,根治性膀胱全切加联合化疗可获得较好疗效。 相似文献
26.
survivin、P53蛋白在非小细胞肺癌的表达及其相关性研究 总被引:3,自引:2,他引:1
目的 :研究survivin、P5 3蛋白在非小细胞肺癌 (NSCLC)组织的表达及其生物学意义 ,并探讨其相关性。 方法 :用免疫组化 (S P法 )染色技术对 95例NSCLC组织石蜡标本进行survivin、P5 3蛋白表达的检测和分析。 结果 :survivin、P5 3在肺癌细胞中阳性表达率 (6 2 .1 %、5 5 .8% )明显高于癌旁的正常肺组织 (1 4 %、7% ) (P <0 .0 1 )。survivin的表达与肿瘤病理分级、组织学分型、淋巴结转移、TNM分期无明显相关 (P >0 .0 5 ) ;P5 3表达与淋巴结转移相关 (P <0 .0 5 ) ,而与肿瘤病理分级、组织学分型、TNM分期无明显相关 (P >0 .0 5 ) ;此外 ,survivin与P5 3蛋白的表达呈显著正相关 (r =0 .5 72 ,P <0 .0 1 )。 结论 :凋亡抑制蛋白survivin与突变型P5 3蛋白在NSCLC的发生发展中可能起协同作用 ,也提示抑癌基因p5 3(野生型 )可能对survivin的表达起负反馈调节作用。survivin和P5 3蛋白可作为靶点用于NSCLC靶向治疗的研究 相似文献
27.
目的总结4例活体部分小肠移植术后早期并发症(1月内)的防治办法,为进一步开展活体小肠移植提供经验。方法4例活体部分小肠移植术后1月内,早期并发症重点在于防治吻合血管血栓、出血、感染、排斥反应、移植肠功能障碍等。结果3例移植受体术后1月内分别发生出血倾向、急性排斥反应、感染、移植肠功能障碍等并发症,但经及时准确的诊断与治疗得以好转,移植肠存活及功能均良好。结论注重活体部分小肠移植术后对于早期并发症的预防及治疗,对于患者预后有重要意义。 相似文献
28.
The interactive role of mucosal T lymphocytes in intestinal growth, development and enteropathy 总被引:2,自引:0,他引:2
Abstract Over the past 15–20 years, research has progressively focused on the mucosal T cell as the central factor in the initiation of physiological or pathological changes, first in the growth and maturation of the early (postnatal) intestine, and second in adult-type enteropathies resulting from sensitivity to either food or pathogen-derived antigens. T cell-mediated events may be measured, for example, in terms of specific immunopathologic patterns of change and injury, such as type 1 (lymphocyte infiltration), type 2 (crypt hyperplasia) and type 3 (flat-destructive), which can be recognized and quantitated microscopically; by determination of lymphocyte reactivity through secretion of interleukin-2 receptors (IL-2R) into plasma or expression by mucosal lymphocytes; by quantitation of lymphocyte subsets emigrating into inflamed tissues by immunoperoxidase-labelled monoclonal antibodies; or by the determination of T cell receptor polymorphisms. Alterations in intestinal growth, structure and function at weaning are likely to be T cell-mediated as they are analogous to the same type 1/2 lesions that reflect modulation of adult mucosal architecture in food and parasite-induced hypersensitivity reactions. Enteropathies associated with HIV infection and T cell deficiency display a milder degree of villous flattening and impaired crypt hyperplasia than that typical of gluten-sensitivity, suggesting a reversion to lesser degrees of mucosal pathology (type 1/2). Clearly more information will accrue; meanwhile the remarks in this brief survey should provide a firm basis whereby clinician and scientist can meet, and together recognize and further dissect the modulatory effect of T lymphocytes on mucosal structure and function. 相似文献
29.
C. Caramella F. Ferrari M. C. Bonferoni M. E. Sangalli M. De Bernardi Di Valserra F. Feletti M. R. Galmozzi 《Biopharmaceutics & drug disposition》1993,14(2):143-160
Six preparations were considered: three multiple unit dosage forms (micropellets in capsules) (D, E and G) and one matrix tablet (B) were experimental prolonged release formulations, two non-disintegrating tablets (A and C) were commercial products. The in vitro dissolution behaviour of the differing formulations was investigated using the USP XXII paddle apparatus. The in vivo study was effected on a panel of 12 healthy volunteers. The two commercial tablets (A and C) showed mean dissolution time (MDT) of 1.34 and 1.44 h and td of 91 and 92 min, respectively; for prolonged release formulations (B, E, D, and G) MDT ranged between 2.28 and 4.23 h and td between 149 and 291 min. The mean residence time (MRT) was 8.68 and 6.47 h for tablets A and C, respectively; it ranged between 9.62 and 10.24 h for the multiple unit formulations E, D, and G and was 11.27 h for matrix B. Formulation B also showed the higher apparent elimination half-life t1/2 (7.12 h), while apparent t1/2 for all the other formulations were very similar, ranging between 5.04 and 5.28 h. High variability between the various formulations was found for Cmax and AUC values, and no relationships could be established with the type of formulation. An in vitro/in vivo correlation was found for all the formulations examined on the basis of analogous parameters (MDT and MRT); (r = 0.83, p <0.05). In a few cases the Wagner-Nelson deconvolution method was applied to individual plasma level versus time curves and the corresponding absorption curves were obtained. In these cases the in vitro/in vivo correlation was tested on the basis of the comparison of the in vivo absorption curves with the in vitro dissolution profiles. This was accomplished using the ‘Levy's plot’ (per cent released versus per cent absorbed) approach and provided further support for the correlation found. 相似文献
30.
血肌酐值法预测地高辛个体化给药方案 总被引:1,自引:0,他引:1
在地高辛常规监测中,用血肌酐值法预测个体化药动学参数和给药方案。结果表明,84例病人的地高辛药物动力学参数预测值为,CL76±21ml/(kg·h),Vd7.05±1.20L/kg,T1/266±7h。预测的个体化剂量为3.1±0.9μg/(kg·d),预测的稳态血药浓度(C_(ss))为1.24±0.38μg/L,与实测C_(ss)1.2±0.4μg/L比较,差异无显著性(P>0.05)。 相似文献